ArticleJournal of the American Association of Nurse Practitioners2016

Apremilast, an oral phosphodiesterase 4 (PDE4) inhibitor: A novel treatment option for nurse practitioners treating patients with psoriatic disease.

Melodie Young et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.